Ovarian cancer is often very aggressive and responds poorly to the therapies currently available. A recent study by Goethe University Frankfurt and University Hospital Frankfurt offers hope that this could change in the medium term.
mRNA therapy revives p53 to combat ovarian tumors
- Post author:
- Post published:January 24, 2024
- Post category:uncategorized